a synthetic Δ 9-THC analogue that is marketed under the brand name Cesamet®(Valeant Pharmaceuticals International) and used for treating patients with chemotherapy-induced nausea and vomiting.

IBS has classically been regarded as a “diagnosis of exclusion,” but new research suggested that might be changing with better diagnostic and treatment approaches.

The SEC's pronouncement focused on four main concerns: impacts from existing regulation and legislation; effects generated by international ... selected group of large pharmaceutical companies ...

The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, ...

The acquisition is the third largest buyout of a home-grown North Carolina bioscience company, trailing Salix’s acquisition by Valeant in 2015 for $11 billion ... Chatham was acquired by Baxter ...

Valeant has gained FDA approval for psoriasis drug Siliq – but side effect warnings about suicidal ideation look set to limit sales. Originally developed by Amgen and AstraZeneca, a suicidal ...

In this article, we are going to take a look at where Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) stands against other top performing European stocks. As per Deloitte, inflation in ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...